Post-COVID-19 rhino-orbito-cerebral mucormycosis-A clinico-mycological study from North India

被引:2
作者
Taneja, Juhi [1 ,7 ]
Chatterjee, Kuhu [1 ]
Sasidharan, Jaseetha [2 ]
Abbas, Syed Zafar [3 ]
Rai, Anil Kumar [2 ]
Raychaudhury, Sujata [4 ]
Das, Bhabatosh [5 ]
Das, Asim [6 ]
机构
[1] ESIC Med Coll & Hosp, Dept Microbiol, Faridabad, India
[2] ESIC Med Coll & Hosp, Dept ENT, Faridabad, India
[3] ESIC Med Coll & Hosp, Dept Radiol, Faridabad, India
[4] ESIC Med Coll & Hosp, Dept Pathol, Faridabad, India
[5] Translat Hlth Sci & Technol Inst, Faridabad, India
[6] ESIC Med Coll & Hosp, Faridabad, India
[7] ESIC Med Coll & Hosp, Dept Microbiol, Faridabad 121001, Haryana, India
关键词
mucormycosis; COVID-19-associated mucormycosis; rhino-orbito-cerebral mucormycosis; antifungal susceptibility; amphotericin B; MANAGEMENT; MUCOR;
D O I
10.1093/mmy/myad067
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The second wave of coronavirus disease 2019 (COVID-19), during the early 2021, lead to a devastating outbreak of mucormycosis in India. This study aimed to determine the aetiology, clinical features, comorbidities, and risk factors of rhino-orbito-cerebral mucormycosis (ROCM) and antifungal susceptibility pattern for the isolates. The study included all suspected cases of ROCM in post-COVID-19 patients attending the hospital from May to December 2021. A total of 70 patients were diagnosed with mucormycosis during the study period. The commonest presentations were rhino-orbital and rhino-orbito-cerebral in 35.7% of cases each. Diabetes mellitus was the commonest associated risk factor in 95.7% of all patients, while 78.5% of the patients were treated with corticosteroids in the recent past, and 25.7% presented with active COVID-19 pneumonia. The commonest isolate was Rhizopus arrhizus n = 14, followed by Aspergillus flavus n = 16, A. fumigatus n = 4, A. niger n = 3, Fusarium oxysporumn = 1, and Apophysomyces variabilisn = 1. Fungal species identification was done by phenotypic methods for all the isolates and DNA sequence analysis of 18 isolates, and antifungal susceptibility testing of 30 isolates was performed by commercially prepared HiMIC plate (HiMedia, Mumbai, India) using broth microdilution for amphotericin B, isavuconazole, itraconazole, voriconazole, and posaconazole. The MIC50 and MIC90 of amphotericin B for R. arrhizus strains were 0.25 and 4 & mu;g/ml, respectively; and the MIC50 and MIC90 results for itraconazole, posaconazole, and isavuconazole were 8 and 8, 2 and 2, and 2 and 8 & mu;g/ml, respectively. In vitro data showed that amphotericin B was the most effective antifungal against most species. The commercially available ready-to-use minimum inhibitory concentration plates are user-friendly for performing antifungal susceptibility, which may be useful in choosing appropriate regimens and monitoring emerging resistance.
引用
收藏
页数:8
相关论文
共 50 条
[31]   Spectrum of magnetic resonance imaging findings in post-COVID-19 patients presenting with rhino-orbito-cerebral mucormycosis in a teaching hospital in Malwa region of Punjab [J].
Singh, Pushpinder ;
Kaur, Kiranjeet ;
Jindal, Vinita ;
Kaur, Manjot ;
Kaur, Mandeep ;
Singh, Navdeep .
JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2022, 11 (12) :7788-7794
[32]   Rhino-orbito-cerebral mucormycosis from dental origin: Case report [J].
Humberto Bravo, Jose ;
Mauricio Agudelo, Andres ;
Cortes, Armando ;
Matta, Lorena .
BIOMEDICA, 2018, 38 (01) :27-31
[33]   Rhino-orbito-cerebral mucormycosis during the COVID-19 third wave in 2021: an Egyptian preliminary report from a single tertiary hospital [J].
Alloush, Taha K. ;
Mansour, Osama ;
Alloush, Adel T. ;
Roushdy, Tamer ;
Hamid, Eman ;
El-Shamy, Mahmoud ;
Shokri, Hossam M. .
NEUROLOGICAL SCIENCES, 2022, 43 (02) :799-809
[34]   Survival in rhino-orbito-cerebral mucormycosis: An international, multicenter ID-IRI study [J].
Cag, Yasemin ;
Erdem, Hakan ;
Gunduz, Mehmet ;
Komur, Suheyla ;
Ankarali, Handan ;
Ural, Serap ;
Tasbakan, Meltem ;
Tattevin, Pierre ;
Tombak, Anil ;
Ozturk-Engin, Derya ;
Tartar, Ayse Sagmak ;
Batirel, Ayse ;
Tekin, Recep ;
Duygu, Fazilet ;
Caskurlu, Hulya ;
Kurtaran, Behice ;
Durdu, Bulent ;
Haciseyitoglu, Demet ;
Rello, Jordi .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 100 :56-61
[35]   Rhino-Orbito-Cerebral Mycosis and COVID-19: From Bad to Worse? [J].
Kulkarni, Rahul ;
Pujari, Shripad ;
Gupta, Dulari ;
Advani, Sikandar ;
Soni, Anand ;
Duberkar, Dhananjay ;
Dhonde, Pramod ;
Batra, Dhruv ;
Bilala, Saurabh ;
Agrawal, Preetesh ;
Aurangabadkar, Koustubh ;
Jain, Neeraj ;
Shetty, Kishorekumar ;
Dhamne, Megha ;
Bolegave, Vyankatesh ;
Patidar, Yogesh ;
More, Aniruddha ;
Nirhale, Satish ;
Rao, Prajwal ;
Pande, Amitkumar ;
Doshi, Suyog ;
Chauvhan, Aradhana ;
Palasdeokar, Nilesh ;
Valzade, Priyanka ;
Jagtap, Sujit ;
Deshpande, Rushikesh ;
Patwardhan, Sampada ;
Purandare, Bharat ;
Prayag, Parikshit .
ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2022, 25 (01) :68-75
[36]   COVID-19 associated Rhino-Orbito-Cerebral Mucormycosis: Imaging spectrum and Clinico-radiological correlation- a single Centre experience [J].
Patel, Dhrumil Deveshkumar ;
Adke, Shrishail ;
Badhe, Padma, V ;
Lamture, Swastika ;
Marfatia, Hetal ;
Mhatre, Pauras .
CLINICAL IMAGING, 2022, 82 :172-178
[37]   Rhino-orbito-cerebral mucormycosis caused by Rhizopus microsporus var. microsporus in a diabetic patient with COVID-19 [J].
Munhoz, Sandy Daniele ;
Lellis, Rute Facchini ;
Carvalho Reis, Ana Paula ;
Barbaro Del Negro, Gilda Maria ;
Teixeira Sousa, Maria Gloria ;
Veasey, John Verrinder .
ANAIS BRASILEIROS DE DERMATOLOGIA, 2022, 97 (04) :501-504
[38]   Molecular diagnosis of rhino-orbito-cerebral mucormycosis from fresh tissue samples [J].
Zaman, Kamran ;
Rudramurthy, Shivaprakash Mandya ;
Das, Ashim ;
Panda, Naresh ;
Honnavar, Prasanna ;
Kaur, Harsimran ;
Chakrabarti, Arunaloke .
JOURNAL OF MEDICAL MICROBIOLOGY, 2017, 66 (08) :1124-1129
[39]   Adverse Drug Reactions to Antifungals Used in the Management of COVID-19 Associated Rhino-Orbito-Cerebral Mucormycosis [J].
Tiwari, Smrati ;
Vakil, Zahaan .
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2022, 13 (02) :197-202
[40]   A case of COVID-19-associated rhino-orbito-cerebral mucormycosis caused by Apophysomyces variabilis with a review of the literature [J].
Erami, Mahzad ;
Mirhendi, Hossein ;
Momen-Heravi, Mansooreh ;
Hezaveh, Seyed Jamal Hashemi ;
Ahsaniarani, Amir Hossein ;
Sabet, Seddighe Sadat ;
Aboutalebian, Shima .
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12